Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Commercialising biomedical technology.

D L Craig

    Australasian Physical & Engineering Sciences in Medicine
    |June 1, 1989
    PubMed
    Summary
    This summary is machine-generated.

    Biomedical technology innovations often fail to reach the market due to a lack of commercialization knowledge. Developing a solid business plan is crucial for licensing products or securing funding to launch new ventures.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Use of microcosms to determine persistence of Escherichia coli in recreational coastal water and sediment and validation with in situ measurements.

    Journal of applied microbiology·2004
    Same author

    Effectiveness of guideline faecal indicator organism values in estimation of exposure risk at recreational coastal sites.

    Water science and technology : a journal of the International Association on Water Pollution Research·2003
    Same author

    Enumeration of faecal coliforms from recreational coastal sites: evaluation of techniques for the separation of bacteria from sediments.

    Journal of applied microbiology·2002
    Same author

    Inhibition of glycogen synthesis by fatty acid in C(2)C(12) muscle cells is independent of PKC-alpha, -epsilon, and -theta.

    American journal of physiology. Endocrinology and metabolism·2002
    Same author

    Ceramide generation is sufficient to account for the inhibition of the insulin-stimulated PKB pathway in C2C12 skeletal muscle cells pretreated with palmitate.

    The Journal of biological chemistry·1999
    Same author

    A low-cost impedance based cryosurgical temperature measurement unit.

    Australasian physical & engineering sciences in medicine·1984
    Same journal

    A comparison between EPSON V700 and EPSON V800 scanners for film dosimetry.

    Australasian physical & engineering sciences in medicine·2020
    Same journal

    Nanodosimetric understanding to the dependence of the relationship between dose-averaged lineal energy on nanoscale and LET on ion species.

    Australasian physical & engineering sciences in medicine·2020
    Same journal

    Schizophrenia diagnosis using innovative EEG feature-level fusion schemes.

    Australasian physical & engineering sciences in medicine·2020
    Same journal

    Force decoding using local field potentials in primary motor cortex: PLS or Kalman filter regression?

    Australasian physical & engineering sciences in medicine·2020
    Same journal

    EPSM 2019, Engineering and Physical Sciences in Medicine : 28-30 October 2019, Perth, Australia.

    Australasian physical & engineering sciences in medicine·2020
    Same journal

    New name: Physical and Engineering Sciences in Medicine.

    Australasian physical & engineering sciences in medicine·2020
    See all related articles

    Area of Science:

    • Biomedical Engineering
    • Technology Commercialization
    • Innovation Management

    Background:

    • Biomedical technology development yields many innovations.
    • A significant number of these innovations do not transition from research settings to market availability.
    • This gap is often attributed to developers' unfamiliarity with commercialization processes.

    Purpose of the Study:

    • To highlight the challenges in commercializing biomedical technology.
    • To outline essential strategies for bringing innovations to market.
    • To emphasize the critical role of a business plan in commercialization.

    Main Methods:

    • Discussion of two primary commercialization pathways: licensing to existing companies or establishing a new company.
    • Emphasis on the necessity of a comprehensive business plan for both strategies.

    Related Experiment Videos

    Main Results:

    • Successful commercialization requires a strategic approach beyond technical development.
    • A well-structured business plan serves as a vital tool for attracting partners or investors.
    • The business plan must clearly articulate profitability for licensing or funding purposes.

    Conclusions:

    • Bridging the gap between biomedical innovation and market entry necessitates understanding commercialization pathways.
    • A robust business plan is indispensable for the successful licensing or venture funding of new biomedical technologies.